AVE 33.3% 0.2¢ avecho biotechnology limited

aod9064 is the real deal., page-11

  1. 10,009 Posts.
    On to the big question of cap raisings. Well with so many projects $100 million would have them all underway. The GFC has ensured that won't happen.

    $35 million would see oxy right thru to FDA approval and add about $500 million to our market cap at that point. POH is in no rush for a cap raising but will need one at some stage.

    By that time we might in a much better place because so much is happening. Some monies might come in from deals etc. So at this point it is not a pressing concern to us.

    POH are courting at least one Global Player who is watching AOD9064 with a very keen interest. So after much discussion about these points I now feel comfortable that by the time we need money the market will b watching POH very closely for the value and quality of their projects.

    SCE will have much more news going forward to build their case for a rerating up to their valuations. Which now sit around 80 cents to $1.oo if AOD is included.

    My personal view is We will see a dollar or much higher at some stage, I just don't want. To pick a time inn the future . So I will keep my investment in place and maybe add as news flows.

    PoS
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.2¢
Change
-0.001(33.3%)
Mkt cap ! $6.338M
Open High Low Value Volume
0.3¢ 0.3¢ 0.2¢ $11.50K 4.335M

Buyers (Bids)

No. Vol. Price($)
63 101422109 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 20872825 7
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.